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This is one of the ﬁrst documented cases of metal-on-metal (MoM) total hip arthroplasty cobalt cardiac
toxicity that has led to patient death. A 69-year-old female presented to our institution with cardiac
failure secondary to cobalt toxicity resulting from bilateral MoM total hip arthroplasty. Her presenting
metal ion levels were a cobalt level of 199 ppb and a chromium level of 77 ppb. She underwent bilateral
femoral revisions to remove the source of cobalt. On postoperative day 7, the patient sustained a cerebral
infarct and eventually expired because of the insult. This case represents one of the ﬁrst documented
fatalities related to MoM cobalt cardiac toxicity.
Copyright © 2015 The Authors. Published by Elsevier Inc. on behalf of American Association of Hip and
Knee Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
Metal-on-metal (MoM) total hip arthroplasty (THA) is no longer
used at most institutions throughout the United States secondary to
increased risks of implant failure [1]. This is largely after numerous
studies documenting the adverse effects and high revision rates
secondary to adverse local tissue reactions such as pseudotumors
associated with this implant [2-4]. Initially, MoM bearing surfaces
were believed to be amethod of eliminating osteolysis secondary to
improved wear characteristics [5]. However, with the use of
modern bearing surfaces (highly crosslinked polyethylene), we
have witnessed improved wear characteristics and decreased
osteolysis [6].
MoM THA can lead to elevated cobalt (Co) and chromium (Cr)
metal ion levels; however, no speciﬁc reference values have been
shown to identify all implants at risk of failure [3,7]. These studies
have suggested that metal ion levels may serve as a surrogate for aclosed potential or pertinent
ent, either direct or indirect,
the biomedical ﬁeld which
rest with this work. For full
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[8]. Increased metal ion levels have been associated with metal-
losis, adverse local tissue reactions, including pseudotumor for-
mation [9]. Although rare, severe systemic side effects can result
after MoM THA [10-12]. Co toxicity may be a cause of many of these
severe systemic manifestations including neurologic and cardiac
symptomatology [13-15]. Two case reports of Co toxicity resulting
in a fatality have been reported previously to our knowledge
[16,17]. We review a rare case of a bilateral MoM THA resulting in
cardiac failure and subsequent mortality.Case history
The patient was a previously healthy 64-year-old female who
presented to an outside institution with a chief complaint of
bilateral hip pain and a preoperative diagnosis of bilateral hip
osteoarthritis. She underwent right THA in 2008 followed by left
THA 10 months later. In each case, a posterior approach was used,
with a MoM bearing surface consisting of a 50-mm acetabular
component, þ2-mm metal liner, and a 36-mm Co alloy head
(DePuy Synthes, Warsaw, Indiana). On follow-up (2-years post-op)
with her primary surgeon, metal ions levels were obtained
secondary to isolated increasing hip pain in both hips. Her
Co levels were found to be markedly elevated to 192 ppb (normal,
<1 ppb; Fig. 1). Her acetabular components were in approximatelyan Association of Hip and Knee Surgeons. This is an open access article under the CC
Figure 1. Preoperative revision anteroposterior pelvis radiograph.
Figure 3. Intraoperative photograph showing dark staining of the surrounding soft
tissue around the acetabulum consistent with metallosis.
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comparison. Revision surgery was being scheduled to address her
hip pain in the setting of elevated metal ion levels at the outside
facility. However, she presented with an impaired renal function
(createnine = 4.1 mg/dL, normal 0.50-1.30 mg/dL) and slowly began
to have increasing shortness of breath. An echocardiogram was
performed documenting severely abnormal right and left ventric-
ular function with an ejection fraction estimated at 10%-15%.
Additionally, a cardiac magnetic resonance imagingwas performed,
which showed “an unusual delayed enhancement pattern and
hyperenhancement of the atria.” The outside cardiologist pro-
ceeded with a cardiac biopsy to rule out Co cardiotoxicity given the
echo and MRI abnormalities in the setting of severely elevated Co
levels.
The patient was transferred to our institution in critical condi-
tion and required the initiation of a biventricular assist device and
extra corporeal circulation. A care conference, including ortho-
paedics, cardiology, and critical care, was held with the patient, and
it was decided that the patient would undergo surgical intervention
instead of nonoperative modalities. The patient underwent bilat-
eral hip revision arthroplasty to exchange the MoM articulation for
a ceramic-on-polyethylene bearing surface. An expeditious
debridement was performed for removal of the damaged tissue
secondary to the patient's medical condition and that she under-
went bilateral surgeries under one anesthetic. No substantial
abductor damage was noted. In each case, ceramic heads were used
with a titanium sleeve (Fig. 2). On the right side, the acetabularFigure 2. Intraoperative photo demonstrating placement of a ceramic femoral head
with a titanium sleeve.component was found to be clinically overly anteverted, and a
lipped liner was used as opposed to revising the acetabular
component. Intraoperative ﬁndings included evidence of metallosis
with gray-stained ﬂuid and tissue on the right sidemore so than the
left (Figs. 3 and 4). Intraoperative cultures were negative. A cystic
mass was also identiﬁed which inﬁltrated each psoas bilaterally
and was not debrided to expedite the surgical procedure. Post-
operative radiographs are shown in Figure 5. Her postoperative
course was complicated by increased drain output (1200 cc of
sanguineous drainage over 8 hours) on postoperative day 3 after
reinitiation of therapeutic anticoagulation and was subsequently
held. Anticoagulation was resumed with intravenous heparin
amidst concern regarding clot formation in the ventricular device
lines. Renal function (increasing creatinine) continued to decline
requiring the initiation of continuous venovenous hemoﬁltration,
and she had a transient episode of acute onset hemiparesis and
aphasia, which was thought to be an embolic event from herFigure 4. The dark-stained tissue was consistent with severe metallosis and pseudo-
tumor tissue after debridement.
Figure 5. Postoperative anteroposterior pelvis radiograph.
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time ruled out an intracranial bleed. She subsequently required
reintubation, and on postoperative day 7 (hospital day 22), she
suffered a hemorrhagic conversion of the previous embolic cere-
brovascular event. At that point, the decision was made to transi-
tion to comfort care. The patient died the following day.
A postmortem autopsy was performed on our patient at the
request of the family. The report was consistent with diffuse Co
deposition throughout the entirety of her body including the heart,
liver, and kidneys. The gross pathology demonstrated evidence of
severe metal staining in the soft tissue samples (Fig. 4). Addition-
ally, the cardiac Co level was elevated to 4.75 mcg/gm of tissue
(normal limit ¼ 0.19 mcg/gm of tissue). The autopsy also conﬁrmed
a hemorrhagic stroke as the ﬁnal insult that led to the patient's
demise.Discussion
Rarely, patients with MoM THA present with elevated metal
ion levels (Co, >20 ppb). Elevated Co levels are currently believedFigure 6. An electron microscopy of the cardiac biopsy that shows increased lipofuscin
and vacuolar spaces consistent with cardiac cobalt toxicity.to be the main cause of patient symptomatology in these cases
[14]. Co toxicity has been well documented in the literature and
can cause cardiomyopathy, hypothyroidism, polycythemia, and
neuropathy complications [12,15,17]. These features were initially
described in beer drinkers in Quebec secondary to a Co product
used for stabilizing the foam layer in beer [13]. The cardiovascular
complications associated with Co toxicity can be as severe as a
dilated cardiomyopathy with patients presenting with fatigue and
shortness of breath approximately 8-40 weeks with elevated Co
metal ion levels [18]. Luckily, there have been only a few cases of
documented cardiotoxicity related to Co toxicity in the ortho-
paedic literature, and this case represents the ﬁrst attempt to
remove the source of Co toxicity by performing revision surgery in
this setting [17,19].
There are numerous proposed treatment options for Co toxicity;
however, no uniform treatment algorithm exists. Isolated Co
toxicity may be treated with metal ion chelators such as edetate
calcium disodium, sodium 2,3-dimercaptopropane sulfonate,
dimercaprol, and N-acetyl-cysteine [19,20]. Chelators work by
binding metal ions and are then excreted from the body, lowering
the overall metal ion levels. However, in total hip replacement, the
source of Co is not removed and Co levels will likely return to
baseline when the metal chelation is discontinued unless the
source is removed. We believe revision and subsequent removal of
CoCr metal heads and liners or cups in the setting of Co toxicity
appear to be the best option at deﬁnitively lowering Co levels
because it completely removes the source of Co.
The pathology report demonstrated elevated cardiac and
serum Co levels in our patient. Our patient presented with a
dilated cardiomyopathy likely secondary to Co toxicity. Her car-
diac biopsy sample revealed a Co level 25 times higher than the
normal limits. The electron microscopy from the cardiac tissue
biopsy showed increased lipofuscin and vacuolar spaces consis-
tent with Co toxicity (Fig. 6). In addition, our pathologists were
able to conﬁrm our clinical impression that Co toxicity likely
contributed to the death of this patient secondary to cardiac
cobaltism.
MoM THA has largely disappeared from use in the United
States. Fatigue and shortness of breath in the setting of MoM THA
may be an indication of Co toxicity, although we acknowledge that
this is exceedingly rare. At this time, we are unable to comment on
screening protocols for patients with similar presentations. A
reasonable algorithm for evaluating and managing patients with
an MoM THA was published by Kwon et al. [4]. There is currently
no cutoff Co level that indicates systemic toxicity, but levels >100
ppb may require further evaluation. In addition, deﬁnitive treat-
ment should include replacement of the CoCr head with a ceramic
head to remove the source of Co. Adjunctive treatment with
chelators may be necessary in the acute period for patient stabi-
lization but do not represent a deﬁnitive management strategy.Summary
This case represents one of the ﬁrst reports of a mortality
associated with Co toxicity secondary to bilateral MoM THA. Co
toxicity has been well deﬁned in the literature and may present as
cardiomyopathy, hypothyroidism, polycythemia, and neuropathy.
These presentations in the setting of THA are rare, and the majority
of reported complications associated with MoM THA are adverse
local tissue reactions. Patients should be worked up with metal ion
levels and possible conﬁrmatory biopsy if clinically indicated.
Treatment should consist of replacement of the CoCr head with a
revision ceramic head and titanium sleeve and possibly the use of
chelators in the setting of acute Co toxicity.
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